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Abstract 
 
Background: Psychological morbidity in individuals with cystic fibrosis (CF) and their caregivers is 
common. The Cystic Fibrosis Foundation (CFF) and European Cystic Fibrosis Society (ECFS) Guidelines 
Committee on Mental Health sought the views of CF health care professionals concerning mental 
health care delivery. 
Methods: An online survey which focused on the current provision and barriers to mental health care 
was distributed to CF health care professionals.  
Results: Of the 1454 respondents, many did not have a colleague trained in mental health issues and 
20% had no one on their team whose primary role was focused on assessing or treating these issues. 
Insufficient resources and a lack of competency were reported in relation to mental health referrals.  
Seventy-three percent of respondents had no experience with mental health screening.  Of those who 
did, they utilized 48 different, validated scales.  
Conclusions: These data have informed the decision-making, dissemination and implementation 
strategies of the Mental Health Guidelines Committee sponsored by the CFF and ECFS.  
 
 
 
 
 
 
 
 
 
1. Introduction  
Recent advances in the diagnosis and clinical management of cystic fibrosis (CF) have led to increased 
survival, but CF remains a life-limiting disease and requires adherence to a complex and demanding 
treatment regimen of up to four hours per day [1].  The evidence for the association between physical 
illness and psychological morbidity, and its effects on outcome, is robust [2]. Children and adults with 
chronic conditions, and their parent caregivers, are at increased risk for depression and anxiety, and 
depressed patients are three times less likely than non-depressed patients to follow through with 
prescribed treatments [3-4].  Psychological distress in people with CF has been associated with worse 
pulmonary function, self-management and health-related quality of life [5-8], in addition to increased 
hospitalizations and health care costs [9].   
 
The International Depression and Anxiety Epidemiological Study (TIDES) recruited over 6,000 patients 
with CF and 4,000 parent caregivers, across nine countries, to answer long-standing questions about 
the prevalence of depression and anxiety in individuals with CF and parent caregivers. Depressive 
symptoms, above the clinical cut-off, were reported by 10% of adolescents, 19% of adults, 37% of 
mothers, and 31% of fathers; symptoms of anxiety, above the cut-off, were reported by 22% of 
adolescents, 32% of adults, 48% of mothers and 36% of fathers. Adolescents whose parents reported 
elevated depressive symptoms were more than twice as likely to report psychological distress 
themselves [10]. The prevalence of psychological morbidity in CF requires serious consideration; 
therefore, the Cystic Fibrosis Foundation (CFF) and European Cystic Fibrosis Society (ECFS) established 
a multidisciplinary Guidelines Committee on Mental Health. To inform the committee’s deliberations 
 
 
 
 
concerning mental health care delivery in CF, the views of the international CF clinical community 
were sought via a survey in both the US and Europe. 
 
2. Methods 
2.1 Survey development and distribution 
A short, 14-item, survey was developed by the authors to assess the current provision of, barriers to 
and perceived needs for mental health care delivery, including the potential implementation of 
standardized screening for depression and anxiety and associated training and resource needs (Figure 
1). To aid completion, forced choice responses and the ranking of items were developed, with an 
opportunity to add further comments. The survey was administered using the web-based tool 
‘SurveyMonkey’ [11] and distributed by the CFF and ECFS to CF health care professionals. In the US, 
the survey was distributed to approximately 2,500 individuals: all CF Centre Directors, Program 
Directors, and Affiliate Directors and to discipline-specific electronic mailing lists (some of which have 
European and Australasian members). In Europe, the ECFS removed duplicates and distributed the 
survey to an additional 1,500 professionals across Europe and beyond. The survey was available for 
completion from 3rd November 2013 to 28th February 2014. 
 
2.2 Data analysis  
The data were downloaded to SPSS 21.  Multiple response frequencies and the mean rank order of 
appropriate items were determined. Thematic analysis of respondents’ comments regarding the 
potential impact of screening was undertaken according to the process described by Braun and Clarke 
 
 
 
 
[12] (familiarisation with the data; coding; searching for, reviewing and defining themes). To aid 
reliability, two independent coders manually identified and agreed on the emergent themes.   
3. Results 
There were 1454 respondents, yielding a response rate of approximately 36%. Forty-five percent of 
the sample came from the US, 49% from 33 European countries, and almost 4% of the sample was 
located in 14 other countries, with the majority from Canada, Australia, New Zealand, South Africa, 
South America and Russia. Two percent did not provide a location.  Table 1 provides the 
characteristics of the sample by location and profession for respondents who provided this 
information (n=1409). The largest professional categories of respondents were physicians, 
physiotherapists and nurses. Social workers, mainly from the US and psychologists, predominantly 
from Europe, were also well- represented among respondents.  
Table 1. Characteristics of the sample: Location and Profession  
 All 
% (n) 
US 
% (n) 
Europe 
% (n) 
Other Location* 
% (n) 
Physician 23.9 (336) 23.0 (150) 24.6 (173) 24.1 (13) 
Physiotherapist 20.2 (284) 11.5 (75) 28.3 (199) 18.5 (10) 
Nurse 18.2 (257) 23.3 (152) 13.9 (98) 13.0 (7) 
Social Worker 11.6 (163) 17.2 (112) 6.7 (47) 7.4 (4) 
Dietician  9.0 (126) 11.4 (74) 6.5 (46) 11.0 (6) 
Psychologist 6.0 (85) 1.2 (8) 10.5 (74) 5.6 (3) 
Researcher 5.2 (73) 8.2 (53) 2.6 (18) 3.7 (2) 
Pharmacist 1.8 (26) 2.5 (16) 0.7 (5) 9.3 (5) 
Psychiatrist 0.8 (11) 0.5 (3) 0.6 (4) 7.4 (4) 
Other Profession+  3.3 (48) 1.2 (8) 5.6 (40) 0 (0) 
Total sample (providing 
both location and profession) 
 
1409 651 
 
704 
 
54 
*Other Location  e.g. Canada, Australia, New Zealand, South Africa, South America, Russia.                                                                                                                              
+Other Profession  e.g. Microbiologist, Geneticist, lung function assistant, hospital teacher, registry coordinator, counsellor. 
 
 
 
 
 
 
3.1 Current mental health care delivery 
In the US, the responsibility for mental health issues primarily rested with social workers (59%) and 
physicians (20%), whereas in Europe it rested with psychologists (52%) and physicians (26%). Of the 
618 respondents in the US and 627 respondents in Europe who replied to question 4, many did not 
have a colleague trained in the specific skills needed to manage mental health conditions: cognitive 
behaviour therapy, counselling and supportive therapies, mental health screening, and prescribing 
medication. The percentages of respondents reporting specific mental health skills training in a CF 
team are provided in Table 2. Twenty-seven percent of US respondents and 37% of those in Europe 
were unable / unsure if they could refer to mental health clinicians in their hospital, and only 52% in 
the US and 39% in Europe had up-to-date lists of mental health resources and referrals to provide to 
patients and families.  
Table 2. Respondents reporting specific mental health skills training in                                                       
a CF team member in the US and Europe 
 US 
(n=618) 
Europe 
(n=627) 
Cognitive Behaviour Therapy  27.2 (168) 31.3 (196) 
Counselling & Supportive Therapies 65.4 (404) 47.5 (298) 
Mental Health Screening 51.3 (317) 32.4 (203) 
Prescribing Medication 22.0 (136) 17.2 (108) 
No one trained in any of these areas 18.3 (113) 27.4 (172) 
 
The majority of respondents (73%) did not have personal experience with systematic screening for 
anxiety and depression. Of those who did, there was a wide variation in the screening measures they 
used. Respondents were asked to identify which screening measure they used from a list of twelve 
validated instruments.  The most common were the Hospital Anxiety and Depression Scale (HADS: 
 
 
 
 
predominantly used in Europe), Beck Depression Inventory (BDI) and the Patient Health Questionnaire 
– 9 (PHQ-9: predominantly used in the US) (Figure 2).   However, respondents reported the use of an 
additional 36 measures, each used by five or fewer respondents, indicating that a total of 48 different 
validated scales were in current use to measure depression and anxiety in CF. 
 
3.2 Perceived barriers and resource recommendations 
Respondents were asked to rank a list of eight potential barriers to screening and seven types of 
assistance that would be helpful in implementing a mental health screening program (from  most to 
least significant barrier / helpful assistance). The responses are presented in Table 3. Further 
comments concerning mental health screening were provided by 472 individuals and these text 
responses were analysed thematically. 165 (35%) reported either no concerns at all or benefits of 
mental health screening. The respondents who voiced concerns (n=307) predominantly perceived 
problems with referrals or in-house capacity for intervention.  For example, 30% (n=93) of those 
raising concerns believed it was unethical to screen if they didn’t have the resources to follow through 
with referral. The lack of trained personnel to administer and score the measures (22%, n=68), the 
time required and clinic flow disruptions (15%, n=46)) were also seen as problematic. Patient / family 
issues were perceived as barriers by 12% (n=36) of respondents, as people with CF and their 
caregivers may be unwilling to be screened or unlikely to follow through referral. The stigma of 
‘labelling’ individuals as having mental health difficulties was also a concern (9%, n=28). Few (2%, n=7) 
respondents believed that screening was not warranted. A few suggested that more comprehensive 
mental health screening, not limited to anxiety and depression, should be implemented. Insufficient 
space to comply with infection control guidelines and provide patient privacy was reported by 5% 
 
 
 
 
(n=16) of respondents. In the US, 5% (n=14) reported that patients may have difficulty obtaining 
insurance coverage for mental health referrals while this barrier was not raised as a concern in Europe 
or other countries.   
Table 3. Barriers and type of assistance perceived to be most helpful in implementing a mental 
health screening program 
Mean rank order of ‘barriers’ and % of respondents who highly ranked barrier to screening (n=1028) 
 Mean Rank order 
(ranked 1-8) 
% respondents ranked 
 within top 3 
Limited staff time 2.49 76 
Limited personnel 3.21 61 
Lack of qualified personnel to provide referrals or 
interventions 
3.60 56 
Patient burden (e.g.  patients’ time) 4.52 30 
Difficult logistics (e.g. screening data storage) 4.71 31 
Patient unwillingness to complete measure 5.32 22 
Space limitations 6.03 16 
Maintaining patient confidentiality / privacy 6.10 7 
 
Mean rank order of ‘assistance’ and percentage of respondents who highly ranked assistance need 
(n=906) 
 Mean Rank order 
(ranked 1-7) 
% respondents ranked 
within top 3 
Additional funds to support a mental health 
professional 
2.75 62  
 
Access to a list of local mental health resources 
and referrals 
3.22 59 
Training in mental health screening 3.56 53 
Access to electronic tools (e.g., tablets, computers) 
for administration and scoring 
4.08 40 
Access to a mental health hotline for guidance 4.18 40 
Training in behavioural interventions (e.g., 
Cognitive Behavioural Therapy) 
4.38 31 
Training in pharmacological interventions (e.g., 
antidepressants) 
5.84 14 
   
3.3 Interest in further training  
Of the 1454 respondents, 968 (67%) expressed an interest in further training in various aspects of 
mental health care. Interested respondents were asked to rank order four potential training topics. 
 
 
 
 
Taking into consideration the top two rankings, there was significant interest within the CF 
community for mental health training at either the North American or European CF Conference. 
Training in mental health screening was requested by 53%, training in counselling or supportive 
therapy skills by 53%, and training in cognitive behavioural therapy by 47%. Eighteen percent of the 
total sample requested training in prescribing psychotropic medication. This included 62% of the 
physicians who responded to the survey, as well as several health care professionals working in roles 
less commonly licensed to prescribe medication in the US and Europe. 
 
4. Discussion 
The data from this survey indicates that the current state of mental health care delivery in CF is 
inadequate and highly variable across care centres and countries. Together with evidence from (a) 
targeted literature reviews, (b) the TIDES data, (c) existing national and international guidelines on 
depression and anxiety in general and in chronically ill populations, and (d) multidisciplinary expert 
opinion, these data from the CF community additionally informed the deliberations of the CFF and 
ECFS Mental Health Guidelines Committee in developing the depression and anxiety guidelines in CF.  
 
The administration of 48 different scales to measure depression and anxiety in CF is astounding. There 
is a clear need for use of standardized instruments with good sensitivity and specificity to allow for 
consistency and comparability between centers and across countries, and to monitor and improve 
individual and populations outcomes over time. In addition, standardizing the choice of screening 
instruments enhances the feasibility and utility of training programs that can support centers in 
implementation [13], possible inclusion of these scores into existing CF registries, and further research 
 
 
 
 
to understand and promote best practice [14]. An additional strength of systematic screening is that it 
creates an opportunity to consider appropriate preventive and supportive interventions for early signs 
of distress, rather than waiting to respond until a more severe psychological impairment emerges.  
Annual screening also provides the opportunity for the CF community to monitor any changes in the 
mental health care needs of patients over time, and to undertake research that focuses on the 
predictors of depression and anxiety and the impact of new disease-modifying therapies on mental 
health outcomes. 
 
When screening for depression, the National Collaborating Centre for Mental Health (UK), U.S. 
Preventive Services Task Force, and Institute for Clinical Systems Improvement advocate the use of 
the PHQ-2 and PHQ-9 where there are appropriate diagnostic, treatment and follow-up services [15-
18]. The PHQ-9 is also recommended in the DSM-V for depression severity assessment [19] and 
endorsed by the American Academy of Pediatrics in their preventive health guidelines [20].  When 
screening for anxiety, the National Collaborating Centre for Mental Health, National Institute for 
Health and Clinical Excellence, British Psychological Society and The Royal College of Psychiatrists 
endorse the use of the Generalised Anxiety Disorder measure, GAD-2 and GAD-7 [21]. 
 
 There was considerable support from respondents to screen for depression and anxiety, although 
presently, the barriers to implementing annual screening require attention and action.  Different 
national implementation strategies will be required to integrate mental health care into CF because of 
the different health care delivery and payment systems in place around the world. For example, 
obtaining insurance coverage and reimbursement are central issues for the US, but not for most 
European countries. The availability, training, and scope of practice of mental health professionals as 
 
 
 
 
part of CF teams also differs by country and region, as determined by local licensure, resources, and 
practice patterns. For example, European CF teams are more likely to include a psychologist, while 
social workers are more likely to be responsible for mental health services in the US.  The primary role 
of CF social workers in the US can vary from case management to skilled psychotherapeutic 
intervention, with disparate caseloads dependent on local practice structures [22,23]. Some US teams 
additionally have access to consultation by psychologists and psychiatrists trained in the care of 
individuals with medical illness. However, the experience of CF clinicians in prescribing psychotropic 
medications and the comfort of mental health clinicians in treating individuals with CF can range 
widely. In the US, the growing role of pediatric primary care clinicians, family practitioners and 
internists in mental health care enables mental health screening to take place in a primary care 
setting. This may provide a helpful adjunct for children and adolescents with CF as these practices are 
child and family-friendly and may help to de-stigmatize mental health issues [24,25]. However, in the 
UK and US, few patients with CF are seen in primary care. 
 
Participation in online surveys is considered easy for people with internet access.  It is an appealing 
method when the sample is widely distributed geographically and the embedded database reduces 
the chance of human error and ensures the integrity of the dataset.   However, one major concern is 
that online surveys typically have a lower response rate than mail and phone surveys [26-28] and e-
mail surveys may be as low as 13% among doctors [28]. The results of this survey may have been 
influenced by non-responder bias in terms of the number of respondents and the varied distribution 
across Europe. However, the response rate of 36% generated representation from all key CF health 
professionals and with a sample size of 1454 generated a low margin of error.  This robust sample 
may be attributed to the recognition of the importance of mental health issues from the CFF and 
 
 
 
 
ECFS, and the growing interest in mental health within CF multidisciplinary teams. It is also recognised 
that some recipients of the survey may not have completed it because another member of their CF 
team had previously responded. As there was more that one respondent from some CF Centres this 
may have also caused bias. Only 295 (20%) of 1454 participants provided an address, but of these, 203 
CF Centres were represented.  
 
As a self-selecting group, respondents were likely to have been more interested and engaged in 
mental health care. If this was the case, it is possible that those who did not respond have less 
training than those who did, reinforcing the need for training and implementation. Nonetheless, this 
survey reveals substantial interest among CF team members in developing additional skills in mental 
health screening, psychotherapy and psychopharmacology.  It is encouraging that large numbers of 
social workers, psychologists and physicians on CF teams are willing to receive further training to 
improve mental health care. Training should address barriers by reviewing the mental health care 
evidence; addressing concerns such as the fear of stigmatizing or alienating patients and caregivers; 
building mental skills in CF health care professionals; and helping CF health care professionals 
navigate local mental health care systems by identifying and addressing gaps, including existing 
internal and external resources and identifying new opportunities. The needs and current resources 
available to support resilience among members of CF care teams in managing the complex stressors 
inherent to their roles were not addressed by this survey but are worthy of future attention [29,30].   
 
The challenge for the future is to make an investment in improving the mental health care capacity in 
CF. As an initial step the CFF and ECFS Committee is developing flexible algorithms for the systematic 
screening, diagnosis and management of depression and anxiety in CF as part of the guideline 
 
 
 
 
recommendations. Implementation will require providing CF health care professionals with (a) 
training, easy access to resources and a toolkit that will enable the implementation of annual mental 
health screening, (b) training for, and the provision of preventive and supportive interventions and (c) 
training and development of referral networks for the subsequent psychological and/or 
pharmacological management of clinically diagnosed depression and anxiety. These steps should 
decrease common barriers to adherence, improve health outcomes and improve the quality of life of 
children and adults with CF and their caregivers.  
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Figure 1.  Mental Health Screening and Intervention: Survey of CF Centres 
1. Please indicate the title below that best describes your role on 
the CF team: 
Advance Practice Nurse 
Dietitian 
Individual with CF 
Nurse Assistant 
Nurse 
Parent/Caregiver 
Pharmacist 
Physician Assistant 
Physician 
Physical Therapist 
Psychiatrist 
Psychologist 
Research Coordinator 
Respiratory Therapist 
Social Worker 
Spouse/Partner 
Other (please specify): 
Mental Health Screening and Intervention: Survey  
2. Where do you live? 
 
3. Do you currently have someone on your team whose primary 
role is to address mental health issues? 
Nurse 
Physician 
Psychiatrist 
Psychologist 
Social worker 
No one holds this role 
Other (please specify): 
Mental Health Screening and Intervention: Survey of  
4. Does anyone on your CF team have training in these areas? 
Check all that apply. Tam Member with Training Continued 
Cognitive Behavioral Therapy (CBT) 
Counseling or supportive therapy 
Mental health screening 
Prescribing medications for depression or anxiety (e.g., 
antidepressants) 
No one on our team is trained in any of these areas 
Other (please specify): 
Mental Health Screening and Intervention: Survey of  
5. Do you have any experience with mental health screenings? 
Yes 
No 
Mental Health Screening and Intervention: Survey of  
6. Which screening measures do you currently use? Check all 
that apply. 
Beck Anxiety Inventory (BAI) 
Beck Scale for Suicidal Ideation (BSI) 
Beck Depression Inventory (BDI) 
Center for Epidemiologic Studies Depression Scale (CESD) 
Children’s Depression Inventory (CDI) 
Hospital Anxiety and Depression Scale (HADS) 
Patient Health Questionnaire – 2 (PHQ2) 
Patient Health Questionnaire – 9 (PHQ9) 
Revised Child Anxiety and Depression Scale (RCADS) 
Revised Children’s Manifest Anxiety Scale (RCMAS) 
Self-Report for Childhood Anxiety Related Disorders (SCARED) 
Zung Depression Inventory 
Other (please specify): 
 
 
 
 
 
 
 
 
 
7. What barriers do you foresee in implementing screening in 
your CF care center? Please rank order the list below, (1 = most 
significant barrier, 2 = second barrier, etc.). 
Difficult logistics (e.g., how and where to store data from 
screening) 
Lack of qualified personnel to provide referrals or interventions 
Limited staff time 
Limited personnel 
Maintaining patient confidentiality/privacy 
Patient burden (e.g., concern about patients’ time and 
availability) 
Patient unwillingness or refusal to complete questionnaires 
Space limitations 
Mental Health Screening and Intervention: Survey  
8. Do you have any concerns about the possible impact of 
mental health screenings on your clinic? If so, what concerns do 
you have? Screening Continued 
 
9. Are you able to make referrals to mental health clinicians in 
your hospital? 
Yes 
No 
I am not sure 
 
10. Do you have an up-to-date list of mental health resources 
and referrals for patients/caregivers in your area? 
Yes 
No 
I am not sure 
Health Screening and Intervention: Survey of  
11. Would you be interested in training in any of the following at 
the North American CF Conference (NACFC) or the European CF 
Society (ECFS) conference? If so, please rank order the list below 
(1 = of most interest, 2 = second interest, etc.). 
Cognitive Behavioural Therapy (CBT) g 
Counselling or supportive therapy g 
Prescribing medications for depression or anxiety (e.g., 
antidepressants)  
Training in Mental Health Screening  
 
12. Please list other mental health training topics that would be 
of interest to you that could be offered at the NACFC or the ECFS 
conference. 
 
13. What type of assistance would be most helpful in 
implementing a mental health screening program? Please rank 
order the list below (1 = most helpful, 2 = second most helpful, 
etc.). 
Access to a list of local mental health resources and referrals 
Access to a mental health hotline for guidance 
Access to electronic tools (e.g., tablets, computers) for 
administration and scoring 
Additional funds to support a mental health professional 
Training in behavioral interventions (e.g., Cognitive Behavioral 
Therapy) 
Training in mental health screening 
Training in pharmacological interventions (e.g., antidepressants) 
 
 
14. Please list other types of assistance that would be helpful to 
you to implement mental health screening at your CF center. 
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Figure 2. Number of respondents using specified instruments in Europe  and the US   (only 
measures used by more than 5 respondents are included)                                     
 
 
 
 
 
 
 
